Analystenmeinungen

Übersicht

Aktionärsstruktur der AstraZeneca PLC

718 News & Informationen zur AstraZeneca Aktie

  • French health regulator recommends compulsory COVID-19 shots for health workers By Reuters
    investing.com

    French health regulator recommends compulsory COVID-19 shots for health workers By Reuters

    French health regulator recommends compulsory COVID-19 shots for health workers

  • Moderna : Saudi Arabia approves Moderna's COVID vaccine -state news agency
    marketscreener.com

    Moderna : Saudi Arabia approves Moderna's COVID vaccine -state news agency

    Saudi Arabia's Food and Drug
    Authority on Friday approved Moderna Inc's COVID-19 vaccine
    for use in the kingdom, the state news agency
    said.
    The authority added that after this… | July 9, 2021

  • EU finds potential link between heart inflammation and mRNA COVID shots By Reuters
    investing.com

    EU finds potential link between heart inflammation and mRNA COVID shots By Reuters

    EU finds potential link between heart inflammation and mRNA COVID shots

  • Countries using Chinese, Astra shots increasingly eye boosters
    businessmirror.com.ph

    Countries using Chinese, Astra shots increasingly eye boosters

    THEY’RE the main source of Covid-19 vaccines for much of the developing world, but concerns over the protection level provided by Chinese developers and AstraZeneca Plc., particularly against the virulent new delta strain, has some countries looking to provide extra doses. Though definitive evidence is yet to emerge validating the…

  • COVID-19 Treatment Clinical Landscape Research Report 2021: Pandemic Perspectives - US FDA Wastes No Time In COVID-19 Emergency Use...
    thestreet.com

    COVID-19 Treatment Clinical Landscape Research Report 2021: Pandemic Perspectives – US FDA Wastes No Time In COVID-19 Emergency Use Authorization Reviews

    DUBLIN, July 9, 2021 /PRNewswire/ — The

  • F-star (FSTX), AstraZeneca Team Up for Novel STING Inhibitors
    zacks.com

    F-star (FSTX), AstraZeneca Team Up for Novel STING Inhibitors

    F-star partners with AstraZeneca for its novel STING inhibitor compounds. Resultantly, F-star's shares rise 9.1%.

  • U.S. Covid-19 hospitalizations rise as Delta Variant spreads
    livemint.com

    U.S. Covid-19 hospitalizations rise as Delta Variant spreads

    Daily admissions rose 6.8% after long decline, while outbreaks among unvaccinated pushed up new cases

  • The Smartest Stocks to Buy With $200 Right Now
    fool.com

    The Smartest Stocks to Buy With $200 Right Now

    You don't need to start with a pile of cash to build wealth on Wall Street.

  • 3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season (Revised)
    investing.com

    3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season (Revised)

    Stocks Analysis by Zacks Investment Research covering: Pfizer Inc, Alexion Pharmaceuticals Inc, AstraZeneca PLC ADR, AbbVie Inc. Read Zacks Investment Research's latest article on Investing.com

  • Sydney to face prolonged COVID-19 lockdown amid record 2021 cases By Reuters
    investing.com

    Sydney to face prolonged COVID-19 lockdown amid record 2021 cases By Reuters

    Sydney to face prolonged COVID-19 lockdown amid record 2021 cases

  • Alexion acquisition by Astrazeneca closing in : stocks
    reddit.com

    Alexion acquisition by Astrazeneca closing in : stocks

    I was typing this post as a question, but since I have now solved the question while I had almost finished writing the post, I will share it anyway …

  • Africa suffers worst surge in Covid cases as delta variant spurs third wave of pandemic
    cnbc.com

    Africa suffers worst surge in Covid cases as delta variant spurs third wave of pandemic

    Covid cases in Africa are doubling every 18 days as the highly contagious delta variant rips through the continent.

  • £312m-plus haul for F-star from AstraZeneca cancer deal
    businessweekly.co.uk

    £312m-plus haul for F-star from AstraZeneca cancer deal

    In an all-Cambridge deal, F-star Therapeutics has lined up a huge payback from a licensing agreement with AstraZeneca. AstraZeneca will receive global rights to research, develop and commercialise next generation Stimulator of Interferon Genes (STING) inhibitor compounds from F-star. F-star is now eligible to receive upfront and near-term payments of up to $12 million. It will

  • Dow Plunges 500 Points As Delta Variant Fears Rattle Markets
    forbes.com

    Dow Plunges 500 Points As Delta Variant Fears Rattle Markets

    The early selloff wiped out two weeks of stock-market gains.

  • F-star Therapeutics rises on agreement with AstraZeneca for STING inhibitors (NASDAQ:AZN)
    seekingalpha.com

    F-star Therapeutics rises on agreement with AstraZeneca for STING inhibitors (NASDAQ:AZN)

    F-star Therapeutics (FSTX) hasadded ~14.3%in the pre-marketafter announcing a licensingagreement with AstraZeneca (AZN) for next-generation Stimulator of Interferon Genes…

  • F-star Therapeutics Enters Into Exclusive Licensing Agreement With AstraZeneca For Novel STING Inhibitors
    thestreet.com

    F-star Therapeutics Enters Into Exclusive Licensing Agreement With AstraZeneca For Novel STING Inhibitors

    CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc.   FSTX (“F-star” or the “Company”), a

  • Surging death toll fails to convince vaccine-wary South Africans
    businesstech.co.za

    Surging death toll fails to convince vaccine-wary South Africans

    One of the world’s fastest pace of deaths from Covid-19 infections hasn’t been able to trounce widespread hesitancy over vaccines in South Africa.

  • Can Novavax Rise To The Manufacturing Challenge?
    forbes.com

    Can Novavax Rise To The Manufacturing Challenge?

    Novavax published results of its U.S. phase 3 trials for its Covid-19 vaccine in mid-June, noting that the shot was over 90% effective overall and 100% effective against moderate and severe disease, roughly in line with Covid vaccine leaders such as Pfizer and Moderna. Although the shot is likely…

  • Delta variant already dominant in U.S., CDC estimates show By Reuters
    investing.com

    Delta variant already dominant in U.S., CDC estimates show By Reuters

    Delta variant already dominant in U.S., CDC estimates show

  • Global Anticoagulants Market (2021 to 2026) - by Drug Class, Route of Administration and Geography
    markets.businessinsider.com

    Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography

    DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…

  • 25 Highest Asthma Rates in the US by City
    insidermonkey.com

    25 Highest Asthma Rates in the US by City

    In this article we will take a look at the 25 highest Asthma Rates in the US by City. You can skip our detailed analysis of these cities and the problem…

  • Sydney extends lockdown as Delta outbreak spreads
    businessmirror.com.ph

    Sydney extends lockdown as Delta outbreak spreads

    A two-week lockdown of Sydney will be extended for at least another seven days as authorities race to stamp out an outbreak of the Delta variant that’s grown to more than 350 cases since mid-June and has spread to an aged-care facility. Current stay-at-home orders—except for exercise, essential shopping and…

  • EUROPEAN MIDDAY BRIEFING: Stocks Rise as Investors Shake Off Wall Street Losses
    marketscreener.com

    EUROPEAN MIDDAY BRIEFING: Stocks Rise as Investors Shake Off Wall Street Losses

    MARKET WRAPS Stocks: European stocks edged higher on Wednesday, shaking off losses on Wall Street triggered in part by softer-than-expected economic data. Resource stocks were leading the…

  • NVIDIA Launches UK’s Most Powerful Supercomputer, for
    globenewswire.com

    NVIDIA Launches UK’s Most Powerful Supercomputer, for

    One of World’s Fastest AI Supercomputers to Enable UK Researchers in Digital Biology, Genomics, Quantum Computing and AI; Five Launch Partners Kicking Off…

  • AstraZeneca (AZN) Gets EC's Clearance for Alexion Acquisition
    zacks.com

    AstraZeneca (AZN) Gets EC's Clearance for Alexion Acquisition

    AstraZeneca (AZN) obtains European Commission's permission for the acquisition of Alexion. The deal is expected to close in the third quarter of 2021.

  • Metro cities halt first dose Covid jab as supply runs out
    businessmirror.com.ph

    Metro cities halt first dose Covid jab as supply runs out

    Several cities in the Philippine capital region have halted their first-dose vaccination programs as supply from the national government runs out. Makati City, home to the nation’s main financial district, said the scheduled inoculation of frontline workers receiving the Covid-19 vaccine for the first time won’t push through on Tuesday.…

  • AstraZeneca : receives clearance from the European Commission for the proposed acquisition of Alexion (Form 6-K)
    marketscreener.com

    AstraZeneca : receives clearance from the European Commission for the proposed acquisition of Alexion (Form 6-K)

    AstraZeneca receives clearance from the European Commission for the proposed acquisition of Alexion

    AstraZeneca's proposed acquisition of Alexion Pharmaceuticals, Inc. has… | July 6, 2021

  • Morning Briefing - International
    cash.ch

  • European business leaders want a stronger hand with China, not decoupling
    livemint.com

    European business leaders want a stronger hand with China, not decoupling

    Executives from top European companies say EU calls for ‘strategic autonomy’ risk protectionism

  • Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research
    markets.businessinsider.com

    Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research

    – Increase in consumer preference from synthetic to bio-based ingredients and development in biotechnology fuel the growth of the global biotech i…

  • Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research
    markets.businessinsider.com

    Biotech Ingredients Market to Garner $75.3 Billion, Globally, By 2028 at 4.8% CAGR, Says Allied Market Research

    PORTLAND, Ore., July 5, 2021 /PRNewswire/ — Allied Market Research published a report, titled, 'Biotech Ingredients Market by Type (Active Pharma…

  • Wallenberg warns against using Covid as excuse for protectionism
    ft.com

    Wallenberg warns against using Covid as excuse for protectionism

    Swedish industrialist says that EU politicians risk creating barriers to global trade

  • Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses
    investing.com

    Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses

    Exclusive: South Korea in talks with mRNA vaccine makers to make up to 1 billion doses – government official

  • Why Coming in Second Could Be Great News for Pfizer and Moderna
    fool.com

  • UAE Approves Use of Moderna Coronavirus Vaccine: Gulf News
    bloombergquint.com

    UAE Approves Use of Moderna Coronavirus Vaccine: Gulf News

    (Bloomberg) —

    The United Arab Emirates, which overtook Seychelles to become the world’s most vaccinated nation, approved the use of coronavirus vaccine produced by Moderna Inc., Dubai-based Gulf News reported.

  • This is the world's most vaccinated nation. But Covid cases remain high
    livemint.com

    This is the world's most vaccinated nation. But Covid cases remain high

    The Persian Gulf nation has so far administered 15.5 million doses, enough to cover 72.1% of its mostly expatriate population of 10 million based on a two-dose regimen

  • These COVID Therapies Appear to Be the Best and Worst at Treating New Variants
    fool.com

    These COVID Therapies Appear to Be the Best and Worst at Treating New Variants

    Here's how several leading COVID-19 antibody therapies compare based on pre-clinical testing.

  • India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
    financialpost.com

    India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19

    Phase-III trials of a vaccine made by India’s Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm said…

  • AstraZeneca : India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
    marketscreener.com

    AstraZeneca : India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19

    Phase-III trials of a vaccine made by
    India's Bharat Biotech showed it was 93.4% effective against
    severe symptomatic COVID-19, the firm said… | July 3, 2021

  • Argentina opens door to U.S. vaccine donations with legal tweak By Reuters
    investing.com

    Argentina opens door to U.S. vaccine donations with legal tweak By Reuters

    Argentina opens door to U.S. vaccine donations with legal tweak

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der AstraZeneca Aktie

Das Unternehmen AstraZeneca PLC aus Großbritannien ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.

ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.

Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care  UCITS  ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten

Dir gefallen die Informationen zu AstraZeneca?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu AstraZeneca?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu AstraZeneca?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu AstraZeneca?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba